Cann Group (ASX: CAN) is a medicinal cannabis company. Cann Group claims the position of the leading Australian medicinal cannabis company. It has the vision of providing access to a range of medicinal cannabis products for patients in Australia and globally.
Has the high ended for companies like Cann Group Ltd (ASX:CAN) and Auscann Group Holdings Ltd (ASX:AC8)?
Both Auscann Group Holdings Ltd (ASX:AC8) and Cann Group Ltd (ASX:CAN) reported their quarterly news this morning.
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX: XAO), is currently down 0.05% at lunch.
Cannabis company Cann Group Ltd (ASX:CAN) announced it has secured a site for Australia’s largest medicinal cannabis operation at Melbourne Airport.
Here are the news headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) on Wednesday. Michael Hill Internationa Ltd (ASX:MHJ) announced an extension to its debt with Australia and New Zealand Banking Group (ASX:ANZ).
Australia’s All Ordinaries (INDEXASX:XAO)(ASX:XAO) closed firmly lower on Wednesday.
The Australian share market, including the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and All Ordinaries (INDEXASX:XAO)(ASX:XAO), closed slightly higher on Thursday.
Shares of Cann Group Limited (ASX:CAN), Auscann Group Holdings Ltd (ASX:AC8), Creso Pharma Ltd (ASX:CPH), Stemcell United Ltd (ASX:SCU) and MMJ Phytotech Ltd (ASX:MMJ) have bounced on the Australian Government’s export approval.
